Literature DB >> 141548

Long-term survival after tricuspid valve replacement. Results with seven different prostheses.

B I Jugdutt, R S Fraser, S J Lee, R E Rossall, J C Callaghan.   

Abstract

The experience with tricuspid valve replacement (TVR) with seven different prostheses, alone or combined with replacement of other valves, in 73 patients (64 rheumatic and nine nonrheumatic) between 1964 and March, 1975, at the University of Alberta Hospital has been reviewed. Early and late mortality rates in rheumatic patients were 41 and 23 percent, respectively (36 percent being alive after a mean of 5.6 years), compared to 33 and 11 percent, respectively, in the nonrheumatic patients (56 percent being alive after a mean of 2 years). Of all survivors, 88 percent were functionally improved. Among the rheumatic patients: (1) 88 percent had organic tricuspid disease; (2) of the 39 patients with tricuspid insufficiency who underwent corrective mitral surgery 7 years before TVR, the tricuspid insufficiency had progressed over the 7 years; (3) the number of patients with tricuspid insufficiency had increased (39 versus 59) over the same 7 year period; (4) a high early mortality rate was encountered in those who were preoperatively in New York Heart Association (N.Y.H.A.) Class IV, or who had cardiomegaly, or pulmonary hypertension, or poor ventricular function, or organic disease, or reoperation; (5) the percentages of survivors with different prostheses were: Starr-Edwards, 31 percent; Beall-Surgitool, 14 percent; Kay-Shiley, 46 percent, Björk-Shiley, 50 percent; Lillehei-Kaster, 100 percent; Cutter-Smeloff and Wada-Cutter, nil. Among the nonrheumatic patients, two with the Cutter-Smeloff, two with the Beall-Surgitool, and one with the Lillehei-Kaster were alive after 14, 37, and 15 months, respectively. Among all survivors of TVR, late thrombus and pannus developed on both ball and disc prostheses (Starr-Edwards, two; Cutter-Smeloff, one; Lillehei-Kaster, one). These findings suggest that TVR should be performed earlier in rheumatic patients to reduce the operative mortality rate and that the Lillehei-Kaster prosthesis is probably most suitable for TVR.

Entities:  

Mesh:

Year:  1977        PMID: 141548

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Tricuspid valve surgery: 15-year experience.

Authors:  M S Bleiweis; C deVirgilio; J C Milliken; F J Baumgartner; B B Sheppard; J M Robertson; R J Nelson
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

2.  A new technique for reconstruction of the tricuspid valve ring in congenital tricuspid insufficiency.

Authors:  C G Montero; G Tellez; E Simarro; A Juffé; J G Amau; R Gurgos; D Figuera; A Cortina
Journal:  Tex Heart Inst J       Date:  1983-06

3.  Evaluation of the Carpentier-Edwards porcine bioprosthesis in the tricuspid position.

Authors:  C Del Campo; H Akalin; F N McKenzie
Journal:  Tex Heart Inst J       Date:  1982-09

4.  Reconstructive surgery for mitral and tricuspid valves--principles and personal experience.

Authors:  J P Bex
Journal:  Jpn J Surg       Date:  1985-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.